On the way to virus-safe blood coagulation factor concentrates

Seminars in Thrombosis and Hemostasis

Volumn 28, Issue SUPPL. 1, 2002, Pages 15-23

  Schimpf, Klaus ^a  

^a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR CONCENTRATE;

BLOOD COMPONENT THERAPY; CONFERENCE PAPER; CRYOPRECIPITATE; HEMOPHILIA; HEPATITIS; HUMAN; INFECTION RISK; JAUNDICE; PRIORITY JOURNAL; UNIVERSITY HOSPITAL; VIRUS INFECTION;

EID: 0036236929     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-30191     Document Type: Conference Paper

References (32)

1. Incidence of viral hepatitis after administration of factor IX concentrates
2. Asymptomatic liver disease in haemophiliacs
3. Australia-SH-antigen und antikörper nach mehrfachtransfusionen bei kindern und jugendlichen bei schwerer und mittelschwerer hämophilie
4. Nebenwirkungen der substitutionstherapie
5. Modifications of factor VIII related antigen in hemophiliacs with acute hepatitis and subclinical liver disease
6. Häufigkeit von klinisch manifester hepatitis B bei 38 hämophilie-patienten unter substitutionstherapie
7. Jaundice and hepatitis B surface antigen and antibody in Greek haemophiliacs
8. Hepatitishäufigkeit, serologische befunde und leberhistologie nach therapie schwerer hämorrhagischer diathesen mit gerinnungsfaktorenkonzentraten
9. Untersuchungen über häufigkeit und verlauf der ikterischen und anikterischen transfusionshepatitis
10. Results of liver biopsies, rate of icteric hepatitis, and frequency of anti-HBs and HBs-antigen in patients of the Heidelberg haemophilia centre
11. Liver biopsy findings in haemophilia
12. Leberhistologie bei 43 patienten mit hämophilie A, B und faktor VII-Mangel. Ergebnisse von 51 biopsien
13. Liver disease in hemophilia
14. Liver biopsy in hemophilia A
15. Progressive liver disease in haemophilia: An understated problem?
16. A clinicopathological study of liver disease in haemophiliacs
17. Percutaneous liver biopsy and chronic liver disease in haemophiliacs
18. Asymptomatic structural liver disease in hemophilia
19. Liver disease in haemophilia
20. Absence of anti-human immundeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia or von Willebrand's disease with pasteurized factor VIII concentrate
21. If nothing goes wrong, is everything all right? Interpreting zero numerators
22. No anti-HIV seroconversion after replacement therapy with steam - Treated factor VIII concentrate-a study of 60 patients with hemophilia A and von Willebrand's disease
23. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions
24. Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate
25. Low risk of viral infection after administration of vapor-heated factor VIII concentrate
26. Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components
27. Transmission of non-A, non-B hepatitis by heat-treated factor VIII concentrate
28. Hepatitishäufigkeit, HBs-andgen- und anti-HBs-frequenz bei patienten des hämophiliezentrums Heidelberg
29. Abnormal serum transaminase levels in patients with factor VIII deficiency
30. Chronic hepatitis in hemophilia
31. Liver dysfunction in patients with hemophilia
32. Chronic liver disease in hemophilia: An update